Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Neffy™ (ARS-1)
FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...
Dave Bloom
-
2022/10/21
If approved, acceptance targeted for mid-2023.
They’re Coming: Needle-Free Emergency Epinephrine Options Currently in Trials
Dave Bloom
-
2022/04/26
For some, the needle is a barrier to administration but alternatives are on the horizon.
CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...
Dave Bloom
-
2022/03/02
The market for epinephrine delivery may expand to include non-needle alternatives next year.
Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting
Dave Bloom
-
2022/02/02
Emergency epinephrine without the jab makes strides.
Emergency Epinephrine Nasal Spray Takes Final Step Toward Approval in EU
Dave Bloom
-
2020/11/30
A needle-free option for administration of epinephrine is on the horizon.
ARS Pharmaceuticals Announces New Patent on ARS-1 (Epinephrine Nasal Spray)
News Wire ~ 3rd Party Press Release
-
2020/07/13
Intranasal delivery of emergency epinephrine takes another step closer to becoming a reality.
Study: Intranasal Epinephrine Absorbed Faster Than Injection and Even Better with...
Dave Bloom
-
2020/03/12
Study compared absorption of epinephrine via nasal spray to that of intramuscular injection.
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
News Wire ~ 3rd Party Press Release
-
2020/03/02
Neffy™ (formally ARS-1) was fast-tracked by the FDA in 2019 as an intranasal alternative to epinephrine auto-injectors.
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
News Wire ~ 3rd Party Press Release
-
2019/02/19
Company provides a novel means of administering emergency epinephrine.